These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 7897302
1. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor. Bergamaschini L, Mannucci PM, Federici AB, Coppola R, Guzzoni S, Agostoni A. J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302 [Abstract] [Full Text] [Related]
2. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes. Bergamaschini L, Santangelo T, Faricciotti A, Ciavarella N, Mannucci PM, Agostoni A. J Immunol; 1996 Feb 01; 156(3):1256-61. PubMed ID: 8558005 [Abstract] [Full Text] [Related]
3. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease. Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP. Thromb Haemost; 2000 Feb 01; 83(2):274-81. PubMed ID: 10739386 [Abstract] [Full Text] [Related]
4. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. Weiss HJ, Sussman II, Hoyer LW. J Clin Invest; 1977 Aug 01; 60(2):390-404. PubMed ID: 17621 [Abstract] [Full Text] [Related]
6. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. Mannucci PM, Tamaro G, Narchi G, Candotti G, Federici A, Altieri D, Tedesco F. Eur J Haematol; 1987 Nov 01; 39(5):467-70. PubMed ID: 3121382 [Abstract] [Full Text] [Related]
12. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease. Schwarz HP, Schlokat U, Mitterer A, Váradi K, Gritsch H, Muchitsch EM, Auer W, Pichler L, Dorner F, Turecek PL. Semin Thromb Hemost; 2002 Apr 01; 28(2):215-26. PubMed ID: 11992244 [Abstract] [Full Text] [Related]
13. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Blood Coagul Fibrinolysis; 2006 Jan 01; 17(1):39-45. PubMed ID: 16607078 [Abstract] [Full Text] [Related]
14. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. De Meyer SF, Vandeputte N, Pareyn I, Petrus I, Lenting PJ, Chuah MK, VandenDriessche T, Deckmyn H, Vanhoorelbeke K. Arterioscler Thromb Vasc Biol; 2008 Sep 01; 28(9):1621-6. PubMed ID: 18556568 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease. Morfini M, Mannucci PM, Tenconi PM, Longo G, Mazzucconi MG, Rodeghiero F, Ciavarella N, De Rosa V, Arter A. Thromb Haemost; 1993 Aug 02; 70(2):270-2. PubMed ID: 8236134 [Abstract] [Full Text] [Related]
18. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia]. Sakai M, Shima M, Izumi Y, Shirahata A. Rinsho Ketsueki; 2004 Mar 02; 45(3):223-7. PubMed ID: 15103936 [Abstract] [Full Text] [Related]
19. The factor VIII/von Willebrand factor complex: basic and clinical issues. Federici AB. Haematologica; 2003 Jun 02; 88(6):EREP02. PubMed ID: 12826528 [Abstract] [Full Text] [Related]